{"transactions":[{"id":930952,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":false,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":7800,"derivative":{"underlying":"Common Stock","underlying_shares":2600},"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930951,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":5000,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930950,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Restricted Stock Units","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":12200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units shall vest in four equal annual installments beginning on January 22, 2027, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":12200,"derivative":{"underlying":"Common Stock","underlying_shares":12200},"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930949,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Stock Option","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-22","kind":"grant","planned":false,"acquired":true,"shares":42600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock option vests with respect to 25% of the underlying shares on January 22, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":42600,"derivative":{"exercise_price":36.76,"expiration_date":"2036-01-22","underlying":"Common Stock","underlying_shares":42600},"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930948,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-25","kind":"tax_withholding","planned":false,"acquired":false,"shares":1126,"price":36.82,"value":41459.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1474,"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930947,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-25","kind":"exercise","planned":false,"acquired":true,"shares":2600,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2600,"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930946,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":1116,"price":36.82,"value":41091.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1384,"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":930945,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2026-01-26T21:48:00.000Z","date":"2026-01-24","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001821460-26-000002","document":"form4-01262026_090155.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000182146026000002/form4-01262026_090155.xml","form_type":"4"}},{"id":1292719,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-28T17:51:34.000Z","date":"2025-01-25","kind":"grant","planned":false,"acquired":true,"shares":10400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":10400,"derivative":{"underlying":"Common Stock","underlying_shares":10400},"source":{"system":"sec-edgar","filing":"0001415889-25-002155","document":"form4-01282025_050131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002155/form4-01282025_050131.xml","form_type":"4"}},{"id":1292718,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Stock Option","published_at":"2025-01-28T17:51:34.000Z","date":"2025-01-25","kind":"grant","planned":false,"acquired":true,"shares":36500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests with respect to 25% of the underlying shares on January 25, 2026, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":36500,"derivative":{"exercise_price":38.01,"expiration_date":"2035-01-25","underlying":"Common Stock","underlying_shares":36500},"source":{"system":"sec-edgar","filing":"0001415889-25-002155","document":"form4-01282025_050131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002155/form4-01282025_050131.xml","form_type":"4"}},{"id":1292717,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Restricted Stock Units","published_at":"2025-01-28T17:51:34.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"date","element":"transactionDate","label":"F2","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"This award of restricted stock units was previously granted on January 24, 2024. The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":7500,"derivative":{"underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001415889-25-002155","document":"form4-01282025_050131.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002155/form4-01282025_050131.xml","form_type":"4"}},{"id":1292716,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T17:51:34.000Z","date":"2025-01-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":865,"price":38.01,"value":32878.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date."}],"balance_after":1635,"source":{"system":"sec-edgar","filing":"0001415889-25-002155","document":"form4-01282025_050131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002155/form4-01282025_050131.xml","form_type":"4"}},{"id":1292715,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2025-01-28T17:51:34.000Z","date":"2025-01-24","kind":"exercise","planned":false,"acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":2500,"source":{"system":"sec-edgar","filing":"0001415889-25-002155","document":"form4-01282025_050131.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588925002155/form4-01282025_050131.xml","form_type":"4"}},{"id":1669181,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Restricted Stock Unit","published_at":"2024-01-26T21:54:25.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units shall vest in four equal annual installments beginning on January 24, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":10000,"derivative":{"underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001415889-24-001870","document":"form4-01262024_090117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924001870/form4-01262024_090117.xml","form_type":"4"}},{"id":1669180,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Stock Option","published_at":"2024-01-26T21:54:25.000Z","date":"2024-01-24","kind":"grant","planned":false,"acquired":true,"shares":47750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date."}],"balance_after":47750,"derivative":{"exercise_price":30.69,"expiration_date":"2034-01-24","underlying":"Common Stock","underlying_shares":47750},"source":{"system":"sec-edgar","filing":"0001415889-24-001870","document":"form4-01262024_090117.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588924001870/form4-01262024_090117.xml","form_type":"4"}},{"id":2095432,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Stock Option","published_at":"2022-12-05T21:10:20.000Z","date":"2022-12-02","kind":"exercise","acquired":false,"shares":38000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock options vests in five equal annual installments beginning on October 1, 2018."}],"balance_after":83729,"derivative":{"exercise_price":8.22,"expiration_date":"2027-10-01","underlying":"Common Stock","underlying_shares":38000},"source":{"system":"sec-edgar","filing":"0001415889-22-012041","document":"form4-12052022_041201.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922012041/form4-12052022_041201.xml","form_type":"4"}},{"id":2095431,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2022-12-05T21:10:20.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":920,"price":60.7109,"value":55854.028,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.67 to $60.77. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001415889-22-012041","document":"form4-12052022_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922012041/form4-12052022_041201.xml","form_type":"4"}},{"id":2095430,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2022-12-05T21:10:20.000Z","date":"2022-12-02","kind":"sale","acquired":false,"shares":37080,"price":60.1199,"value":2229245.892,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.67 to $60.66. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":920,"source":{"system":"sec-edgar","filing":"0001415889-22-012041","document":"form4-12052022_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922012041/form4-12052022_041201.xml","form_type":"4"}},{"id":2095429,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF STRATEGY OFFICER"}}],"security":"Common Stock","published_at":"2022-12-05T21:10:20.000Z","date":"2022-12-02","kind":"exercise","acquired":true,"shares":38000,"price":8.22,"value":312360.0,"ownership":{"direct":true},"balance_after":38000,"source":{"system":"sec-edgar","filing":"0001415889-22-012041","document":"form4-12052022_041201.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000141588922012041/form4-12052022_041201.xml","form_type":"4"}},{"id":3037211,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Series C Preferred Stock","published_at":"2020-09-04T21:19:37.000Z","date":"2020-08-21","kind":"exercise","acquired":false,"shares":51021,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock automatically converted on a 8.215-for-one basis into common stock upon the closing of the Issuer's initial public offering, with any fractional shares resulting from the conversion of the aggregate preferred stock held by the reporting person canceled in exchange for cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock automatically converted on a 8.215-for-one basis into common stock upon the closing of the Issuer's initial public offering, with any fractional shares resulting from the conversion of the aggregate preferred stock held by the reporting person canceled in exchange for cash."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock automatically converted on a 8.215-for-one basis into common stock upon the closing of the Issuer's initial public offering, with any fractional shares resulting from the conversion of the aggregate preferred stock held by the reporting person canceled in exchange for cash."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Includes 443.27 shares of common stock received upon the payment of an in-kind dividend on the Series C Preferred Stock on August 21, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6653.98},"source":{"system":"sec-edgar","filing":"0000899243-20-024370","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320024370/doc4a.xml","form_type":"4/A","original_submission_date":"2020-08-25"}},{"id":3037210,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Series A Preferred Stock","published_at":"2020-09-04T21:19:37.000Z","date":"2020-08-21","kind":"exercise","acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock automatically converted on a 8.215-for-one basis into common stock upon the closing of the Issuer's initial public offering, with any fractional shares resulting from the conversion of the aggregate preferred stock held by the reporting person canceled in exchange for cash."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock automatically converted on a 8.215-for-one basis into common stock upon the closing of the Issuer's initial public offering, with any fractional shares resulting from the conversion of the aggregate preferred stock held by the reporting person canceled in exchange for cash."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock automatically converted on a 8.215-for-one basis into common stock upon the closing of the Issuer's initial public offering, with any fractional shares resulting from the conversion of the aggregate preferred stock held by the reporting person canceled in exchange for cash."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Includes 2,693.34 shares of common stock received upon the payment of an in-kind dividend on the Series A Preferred Stock on August 21, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":27039.05},"source":{"system":"sec-edgar","filing":"0000899243-20-024370","document":"doc4a.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320024370/doc4a.xml","form_type":"4/A","original_submission_date":"2020-08-25"}},{"id":3037209,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-09-04T21:19:37.000Z","date":"2020-08-21","kind":"exercise","acquired":true,"shares":33693,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock automatically converted on a 8.215-for-one basis into common stock upon the closing of the Issuer's initial public offering, with any fractional shares resulting from the conversion of the aggregate preferred stock held by the reporting person canceled in exchange for cash."}],"balance_after":33693,"source":{"system":"sec-edgar","filing":"0000899243-20-024370","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320024370/doc4a.xml","form_type":"4/A","original_submission_date":"2020-08-25"}},{"id":3047306,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Series C Preferred Stock","published_at":"2020-08-25T23:42:03.000Z","date":"2020-08-21","kind":"exercise","acquired":false,"shares":51681,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F3","text":"Includes 661 shares received upon the payment of an in-kind dividend on the Series C Preferred Stock on August 21, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"Includes 661 shares received upon the payment of an in-kind dividend on the Series C Preferred Stock on August 21, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":6871},"source":{"system":"sec-edgar","filing":"0000899243-20-023394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320023394/doc4.xml","form_type":"4"}},{"id":3047305,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Series A Preferred Stock","published_at":"2020-08-25T23:42:03.000Z","date":"2020-08-21","kind":"exercise","acquired":false,"shares":207869,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of preferred stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering."},{"field":"shares","element":"transactionShares","label":"F2","text":"Includes 7,869 shares received upon the payment of an in-kind dividend on the Series A Preferred Stock on August 21, 2020."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of preferred stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of preferred stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Includes 7,869 shares received upon the payment of an in-kind dividend on the Series A Preferred Stock on August 21, 2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":32214},"source":{"system":"sec-edgar","filing":"0000899243-20-023394","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320023394/doc4.xml","form_type":"4"}},{"id":3047304,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-08-25T23:42:03.000Z","date":"2020-08-21","kind":"exercise","acquired":true,"shares":6871,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering."}],"balance_after":39085,"source":{"system":"sec-edgar","filing":"0000899243-20-023394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320023394/doc4.xml","form_type":"4"}},{"id":3047303,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Common Stock","published_at":"2020-08-25T23:42:03.000Z","date":"2020-08-21","kind":"exercise","acquired":true,"shares":32214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of preferred stock automatically converted on a one-for-one basis into Common stock upon the closing of the Issuer's initial public offering."}],"balance_after":32214,"source":{"system":"sec-edgar","filing":"0000899243-20-023394","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320023394/doc4.xml","form_type":"4"}},{"id":3050614,"issuer":{"id":4381,"kind":"organization","name":"Harmony Biosciences Holdings, Inc.","symbol":"HRMY"},"owners":[{"id":68770,"kind":"person","name":"Serafin Andrew","position":1,"cik":"0001821460","reported_name":"Serafin Andrew","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Business Officer"}}],"security":"Stock Option","published_at":"2020-08-21T00:05:44.000Z","date":"2020-08-18","kind":"grant","acquired":true,"shares":81875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option shall vest in five equal annual installments beginning on August 21, 2021."}],"balance_after":81875,"derivative":{"exercise_price":24,"expiration_date":"2030-08-18","underlying":"Common Stock","underlying_shares":81875},"source":{"system":"sec-edgar","filing":"0000899243-20-023130","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802665/000089924320023130/doc4.xml","form_type":"4"}}]}